These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 30113430)
21. [Progress in neoadjuvant and transformation therapy of pancreatic cancer]. Hu DD; Dai MH Zhonghua Wai Ke Za Zhi; 2017 Jan; 55(1):69-72. PubMed ID: 28056259 [TBL] [Abstract][Full Text] [Related]
22. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas. Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic advances in metastatic pancreatic adenocarcinoma and related cancers: focus on evidence-based and sequenced approaches to survival extension in metastatic pancreatic adenocarcinoma. Bekaii-Saab T; Yu K; Lima CMSR; Wolin EM Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):1-16. PubMed ID: 30807558 [No Abstract] [Full Text] [Related]
24. The case for routine use of adjuvant therapy in pancreatic cancer. Kennedy EP; Yeo CJ J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543 [TBL] [Abstract][Full Text] [Related]
25. Aggressive surgery for borderline resectable pancreatic cancer: evaluation of National Comprehensive Cancer Network guidelines. Yamada S; Fujii T; Sugimoto H; Nomoto S; Takeda S; Kodera Y; Nakao A Pancreas; 2013 Aug; 42(6):1004-10. PubMed ID: 23532000 [TBL] [Abstract][Full Text] [Related]
26. [Adenocarcinoma of the pancreas. Therapeutic strategies]. André T; Balosso J; Louvet C; Houry S; Vaillant JC; Touboul E; Lotz JP; de Gramont A; Izrael V Presse Med; 1998 Mar; 27(11):539-45. PubMed ID: 9767970 [TBL] [Abstract][Full Text] [Related]
27. Impact of Different Treatment Modalities on the Outcome of Pancreatic Cancer. Khan M; Ashraf MI; Syed AA; Hanif F J Coll Physicians Surg Pak; 2017 Aug; 27(8):470-474. PubMed ID: 28903837 [TBL] [Abstract][Full Text] [Related]
28. Span-1 and CA19-9 as Predictors of Early Recurrence and Lymph Node Metastasis for Patients with Invasive Pancreatic Cancer after Pancreatectomy. Shimizu T; Asakuma M; Tomioka A; Inoue Y; Hirokawa F; Hayashi M; Uchiyama K Am Surg; 2018 Jan; 84(1):109-113. PubMed ID: 29428036 [TBL] [Abstract][Full Text] [Related]
29. [Hormone therapy of postoperative recurrent pancreatic carcinoma with octreotide and tamoxifen]. Wenger FA; Zieren HU; Jacobi CA; Müller JM Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1348-50. PubMed ID: 9931878 [TBL] [Abstract][Full Text] [Related]
30. Type of Resection (Whipple vs. Distal) Does Not Affect the National Failure to Provide Post-resection Adjuvant Chemotherapy in Localized Pancreatic Cancer. Bergquist JR; Ivanics T; Shubert CR; Habermann EB; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB; Truty MJ Ann Surg Oncol; 2017 Jun; 24(6):1731-1738. PubMed ID: 28070725 [TBL] [Abstract][Full Text] [Related]
31. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy. Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P Oncology; 2015; 89(1):37-46. PubMed ID: 25766660 [TBL] [Abstract][Full Text] [Related]
32. Role of surgery in pancreatic cancer. Buanes TA World J Gastroenterol; 2017 Jun; 23(21):3765-3770. PubMed ID: 28638216 [TBL] [Abstract][Full Text] [Related]
33. Multimodality management of localized pancreatic cancer. Wayne JD; Wolff RA; Pisters PW; Evans DB Cancer J; 2001; 7 Suppl 1():S35-46. PubMed ID: 11504284 [TBL] [Abstract][Full Text] [Related]
34. [Clinical study of the month. Adjuvant radio-chemotherapy and chemotherapy following curative resection of pancreatic cancer: results of the randomized trial ESPAC-1]. Polus M; Jerusalem G; Sautois B; Silvestre RM; Collette MY; Closon MT; Fillet G Rev Med Liege; 2002 Feb; 57(2):119-22. PubMed ID: 11942178 [TBL] [Abstract][Full Text] [Related]
35. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. Hoffman JP; Lipsitz S; Pisansky T; Weese JL; Solin L; Benson AB J Clin Oncol; 1998 Jan; 16(1):317-23. PubMed ID: 9440759 [TBL] [Abstract][Full Text] [Related]
36. Hepatobiliary and pancreatic: sigmoidal mesenterial lymph node metastasis from pancreatic cancer. Itoyama R; Hashimoto D; Chikamoto A; Hayashi H; Beppu T; Baba H J Gastroenterol Hepatol; 2014 Dec; 29(12):1953. PubMed ID: 25404108 [No Abstract] [Full Text] [Related]
37. Radiochemotherapy in the management of pancreatic cancer--part II: use in adjuvant and locally unresectable settings. Dickler A; Abrams RA Semin Radiat Oncol; 2005 Oct; 15(4):235-44. PubMed ID: 16183477 [TBL] [Abstract][Full Text] [Related]
39. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer. Ghaneh P; Neoptolemos JP Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935 [TBL] [Abstract][Full Text] [Related]
40. [Locally advanced pancreatic adenocarcinoma. Chemoradiotherapy, reevaluation and secondary resection]. Delpero JR; Turrini O Cancer Radiother; 2006 Nov; 10(6-7):462-70. PubMed ID: 16987678 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]